Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience
Siobhan McKay, Samir Pathak, Richard Wilkin, Sivesh K. Kamarajah, Stephen J. Wigmore, Jonathan Rees, Declan F.J. Dunne, Giuseppe Garcea, Jawad Ahmad, Nicola de Liguori Carino, Asma Sultana, Mike Silva, Pavlos Lykoudis, David Nasralla, James Milburn, Nehal Shah, Hemant M. Kocher, Ricky H. Bhogal, Ryan Baron, Alex Navarro, James Halle‐Smith, Bilal Al‐Sarireh, Gourab Sen, Nigel B. Jamieson, C Briggs, David Stell, Somaiah Aroori, Matthew Bowles, Aditya Kanwar, Simon Harper, Krishna Menon, Andreas Prachalias, Parthi Srinivasan, Adam E. Frampton, Claire Jones, Ali Arshad, Iain S. Tait, Duncan Spalding, Alastair L. Young, Damien Durkin, Manijeh Ghods-Ghorbani, Robert P. Sutcliffe, Keith Roberts
Topics & Concepts
MedicinePandemicCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakPancreatic cancerCancerVirologyInternal medicineDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 and healthcare impactsPancreatic and Hepatic Oncology ResearchCOVID-19 Clinical Research Studies